Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences NanoPharmaceuticals

Venkateswarlu Vobalaboina's Biography

Venkateswarlu Vobalaboina, Managing Director, Neuheit Pharma Technologies Pvt Ltd

Dr. V. Venkateswarlu is a highly motivated scientist with in depth knowledge in pharmaceutical sciences, dedicated researcher and co-founder of NEUHEIT pharma technologies PVT Ltd. The company is engaged in the development of complex generic and differentiated products from ideation to commercialization. It also offers consultancy services in all disciplines of pharmaceutical product development including Bioequivalence studies.

A post-doc in pharmaceutical sciences with 16 years of teaching and research experience at University College of Pharmaceutical Sciences, Kakatiya University, warangal, India and Head, Formulations, Biostudies and Packaging for 8 years in Dr.Reddy's Laboratories Ltd, Hyderabad.

Dr. Venkateswarlu is involved in the development of ANDAs for USA, dossiers for regulated and RoW markets, developed differentiated products and created platform technology in microspheres. Project selection, design around strategy development, smooth execution of strategy with DoE and QbD principles, Scale up, technology transfer, exhibit batches execution, bio-relevant media development for biosuccess, QBR and QbD based PDR, and flawless dossier compilation are the critical steps handled by Dr. Venkateswarlu effectively. In addition, application of critical chain project management principles, theory of constraints, six sigma principles and use of IVIVC/R are the key areas that helped for his success.

Venkateswarlu Vobalaboina Image

Lipid NanoParticle Drug Delivery Systems

Thursday, 10 September 2015 at 14:10

Add to Calendar ▼2015-09-10 14:10:002015-09-10 15:10:00Europe/LondonLipid NanoParticle Drug Delivery SystemsNanoPharmaceuticals in

The presentation covers, selection of formulation ingredients, different methods of preparation of lipid nanoparticles, inclusion of homing devices to achieve targeted drug delivery, characterization of Nano systems, assessment of performance of nanoparticles and applications in pharmaceutical industry.Discussion on specific problems association with formulation, stabilization and manufacturing of these dosage forms will also be presented. Further, regulatory requirements, Quality control, intellectual property and manufacturing issues of NDDS will be presented. Finally, discussion on future research areas and potential of lipid nanoparticle drug delivery systems in industrial applications is presented.

Add to Calendar ▼2015-09-10 00:00:002015-09-11 00:00:00Europe/LondonNanoPharmaceuticalsNanoPharmaceuticals in